<DOC>
	<DOCNO>NCT02646995</DOCNO>
	<brief_summary>The purpose trial evaluate use newly develop lipid formulation versus fish oil would well enable absorption essential fatty acid 12 week supplementation .</brief_summary>
	<brief_title>Lipid Formulation Increase Bioavailability Fatty Acids Cystic Fibrosis ( CF ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>1 . Previously diagnose CF accord establish criterion ( diagnosis CF base either two positive sweat chloride test &gt; 60 mEq/L identification two detectable mutation associate CF ) 2 . Exocrine pancreatic insufficiency define pathological fecal elastase ( &lt; 15µg/g ) find Medical History patient 3 . Informed consent letter sign date parent legal guardian inclusion study , assent sign date child ≥ 14 year old 1 . Any change ( initiation , change type drug , dose modification , schedule modification , interruption , discontinuation , reinitiation ) chronic treatment/prophylaxis regimen CF CFrelated condition within 4 week prior baseline 2 . Exposure another investigational drug dietary supplement enteral nutrition contain EPA docosahexaenoic acid ( DHA ) , Fish use supplement contain fish oil within 4 week prior baseline . 3 . Treatment intravenous antibiotic within 4 week prior baseline 4 . Newly start oral antibiotic treatment within 4 week prior Baseline 5 . History solid organ hematological transplantation 6 . Ongoing immunosuppressive therapy ( corticosteroid ) within 3 week prior baseline 7 . Major complication lung disease ( include massive hemoptysis , pneumothorax , pleural effusion ) within 8 week prior baseline 8 . Evidence pulmonary exacerbation acute upper low respiratory tract infection ( include viral illness ) within 3 week prior baseline 9 . Having donate blood transfusion blood/blood product trial 3 month prior screen expect study 10 . Any bleed disorder screen 11 . Patient expect comply study procedure . 12 . Currently participate participate another clinical trial within 8 week prior baseline . 13 . Any known food allergy 14 . Incapacity swallow capsule</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>